前列腺特异性抗原同源异构体2在前列腺癌诊治中的研究进展
Research progress of prostate specific antigen isoform 2 in the diagnosis and treatment of prostate cancer
鄢超 1令狐志宏 1王晶莹 1师庆红 1焦美玲 1王思博 1宋丽娜1
作者信息
- 1. 吉林大学中日联谊医院检验科,长春 130033
- 折叠
摘要
前列腺癌是目前全球男性发病率居第二位的恶性肿瘤.在我国其发病率虽然低于欧美国家,但病死率却明显偏高.前列腺特异性抗原同源异构体2(p2PSA)是前列腺特异性抗原(PSA)的前体形式,也是近年新发现的前列腺癌的生物标志物之一,广泛用于前列腺癌的诊断、预测、疗效评估等研究,本文将对近年来p2PSA在前列腺癌诊治中的研究进展作一综述.
Abstract
Prostate cancer is the second malignant tumor in the world with the highest incidence rate of men.In China,although its incidence rate is lower than that of European and American countries,its case fatality rate is sig-nificantly higher.Prostate specific antigen isoform 2(p2PSA)is a precursor form of prostate specific antigen(PSA)and one of the newly discovered biomarkers for prostate cancer in recent years.It is widely used in the diagnosis,pre-diction,and efficacy evaluation of prostate cancer.This article will review the research progress of p2PSA in the diag-nosis and treatment of prostate cancer in recent years.
关键词
前列腺特异性抗原同源异构体2/前列腺癌/诊治Key words
Prostate specific antigen isoform 2/Prostate cancer/Diagnosis and treatment引用本文复制引用
出版年
2024
NETL
NSTL
万方数据